resveratrol has been researched along with Cancer of Colon in 115 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 43 (37.39) | 29.6817 |
| 2010's | 60 (52.17) | 24.3611 |
| 2020's | 12 (10.43) | 2.80 |
| Authors | Studies |
|---|---|
| Chajkowisk, S; Conney, A; Lee, HJ; Mizuno, CS; Paul, S; Rimando, AM; Rimoldi, JM; Suh, N; Zheng, X | 1 |
| Chen, X; Evers, BM; Kril, LM; Liu, C; Rychahou, P; Shi, J; Sviripa, V; Watt, DS; Yu, T; Zhang, W | 1 |
| Kubo, A; Sudo, H | 1 |
| Hong, M; Hou, JG; Li, YF; Wang, Y; Yang, YM; Yu, L | 1 |
| Biray Avci, C; Caglar, HO; Cesmeli, S; Goker Bagca, B; Gunduz, C; Ozates, NP | 1 |
| Chamsai, B; Opanasopit, P; Samprasit, W | 1 |
| Deng, Y; He, B; Luo, H; Qin, X; Yao, X; Zhang, J | 1 |
| Gündoğdu, AÇ; Özyurt, R | 1 |
| Dang, X; Deng, H; Gao, Y; Hui, Z; Jiang, SW; Ma, S; Qi, X; Xie, T; Xu, B; Ye, XY; Yuan, Y | 1 |
| Conesa, I; López-Nicolás, JM; Matencio, A; Navarro-Orcajada, S; Vidal-Sánchez, FJ | 1 |
| Huang, D; Huang, H; Ma, S; Ruan, S; Shen, M; Sun, L; Wasan, HS; Yuan, L; Zhang, K; Zhou, M | 1 |
| Arun, G; Kannan, PR; Madhan, B; Mary, SA; Senthil Kumar, C; Thangam, R | 1 |
| Aasbrenn, M; Abd El-Aty, AM; Abdu, A; Abraha, HB; Achour, A; Acquaroni, M; Addeo, P; Agback, P; Agback, T; Al-Alwan, M; Al-Mazrou, A; Al-Mohanna, F; Aliste, M; Almquist, J; Andel, J; Ando, M; Angelov, A; Annuar, MSM; Antwi, K; Arroliga, AC; Arruda, SLM; Asch, SM; Averous, G; Ayaz, S; Ayer, GB; Bachellier, P; Ball, S; Banijamali, AR; Barden, TC; Bartoncini, S; Bedanie, G; Bellò, M; Benić, F; Berhe, GG; Bertiger, G; Beumer, JH; Bhandari, B; Bond, DS; Boules, M; Braüner Christensen, J; Brown-Johnson, C; Burgstaller, S; Cao, L; Capasso, C; Carlevato, R; Carvalho, AE; Ceci, F; Chagas, ATA; Chavan, SG; Chen, AP; Chen, HC; Chen, J; Chen, Q; Chen, Y; Chen, YF; Christ, ER; Chu, CW; Covey, JM; Coyne, GO'; Cristea, MC; Currie, MG; Dahdal, DN; Dai, L; Dang, Z; de Abreu, NL; de Carvalho, KMB; de la Plaza Llamas, R; Deandreis, D; Del Prete, S; Dennis, JA; Deur, J; Díaz Candelas, DA; Divyapriya, G; Djanani, A; Dodig, D; Doki, Y; Doroshow, JH; Dos Santos, RC; Durairaj, N; Dutra, ES; Eguchi, H; Eisterer, W; Ekmann, A; Elakkad, A; Evans, WE; Fan, W; Fang, Z; Faria, HP; Farris, SG; Fenoll, J; Fernandez-Botran, R; Flores, P; Fujita, J; Gan, L; Gandara, DR; Gao, X; Garcia, AA; Garrido, I; Gebru, HA; Gerger, A; Germano, P; Ghamande, S; Ghebeh, H; Giver Jensen, T; Go, A; Goichot, B; Goldwater, M; Gontero, P; Greil, R; Gruenberger, B; Guarneri, A; Guo, Y; Gupta, S; Haxholdt Lunn, T; Hayek, AJ; He, ML; Hellín, P; Hepprich, M; Hernández de Rodas, E; Hill, A; Hndeya, AG; Holdsworth, LM; Hookey, L; Howie, W; Hu, G; Huang, JD; Huang, SY; Hubmann, E; Hwang, SY; Imamura, H; Imperiale, A; Jiang, JQ; Jimenez, JL; Jin, F; Jin, H; Johnson, KL; Joseph, A; Juwara, L; Kalapothakis, E; Karami, H; Karayağiz Muslu, G; Kawabata, R; Kerwin, J; Khan, I; Khin, S; Kidanemariam, HG; Kinders, RJ; Klepov, VV; Koehler, S; Korger, M; Kovačić, S; Koyappayil, A; Kroll, MH; Kuban, J; Kummar, S; Kung, HF; Kurokawa, Y; Laengle, F; Lan, J; Leal, HG; Lee, MH; Lemos, KGE; Li, B; Li, G; Li, H; Li, X; Li, Y; Li, Z; Liebl, W; Lillaz, B; Lin, F; Lin, L; Lin, MCM; Lin, Y; Lin, YP; Lipton, RB; Liu, J; Liu, W; Liu, Z; Lu, J; Lu, LY; Lu, YJ; Ludwig, S; Luo, Y; Ma, L; Ma, W; Machado-Coelho, GLL; Mahmoodi, B; Mahoney, M; Mahvash, A; Mansour, FA; Mao, X; Marinho, CC; Masferrer, JL; Matana Kaštelan, Z; Melendez-Araújo, MS; Méndez-Chacón, E; Miletić, D; Miller, B; Miller, E; Miller, SB; Mo, L; Moazzen, M; Mohammadniaei, M; Montaz-Rosset, MS; Mousavi Khaneghah, A; Mühlethaler, K; Mukhopadhyay, S; Mulugeta, A; Nambi, IM; Navarro, S; Nazmara, S; Neumann, HJ; Newman, EM; Nguyen, HTT; Nicolato, AJPG; Nicolotti, DG; Nieva, JJ; Nilvebrant, J; Nocentini, A; Nugent, K; Nunez-Rodriguez, DL; Nygren, PÅ; Oberli, A; Oderda, M; Odisio, B; Oehler, L; Otludil, B; Overman, M; Özdemir, M; Pace, KA; Palm, H; Parchment, RE; Parise, R; Passera, R; Pavlovic, J; Pecherstorfer, M; Peng, Z; Pérez Coll, C; Petzer, A; Philipp-Abbrederis, K; Pichler, P; Piekarz, RL; Pilati, E; Pimentel, JDSM; Posch, F; Prager, G; Pressel, E; Profy, AT; Qi, P; Qi, Y; Qiu, C; Rajasekhar, B; Ramia, JM; Raynor, HA; Reis, VW; Reubi, JC; Ricardi, U; Riedl, JM; Romano, F; Rong, X; Rubinstein, L; Rumboldt, Z; Sabir, S; Safaeinili, N; Sala, BM; Sandoval Castillo, L; Sau, M; Sbhatu, DB; Schulte, T; Scott, V; Shan, H; Shao, Y; Shariatifar, N; Shaw, JG; She, Y; Shen, B; Shernyukov, A; Sheth, RA; Shi, B; Shi, R; Shum, KT; Silva, JC; Singh, A; Sinha, N; Sirajudeen, AAO; Slaven, J; Sliwa, T; Somme, F; Song, S; Steinberg, SM; Subramaniam, R; Suetta, C; Sui, Y; Sun, B; Sun, C; Sun, H; Sun, Y; Supuran, CT; Surger, M; Svartz, G; Takahashi, T; Takeno, A; Tam, AL; Tang, Z; Tanner, JA; Tannich, E; Taye, MG; Tekle, HT; Thomas, GJ; Tian, Y; Tobin, JV; Todd Milne, G; Tong, X; Une, C; Vela, N; Venkateshwaran, U; Villagrán de Tercero, CI; Wakefield, JD; Wampfler, R; Wan, M; Wang, C; Wang, J; Wang, L; Wang, S; Waser, B; Watt, RM; Wei, B; Wei, L; Weldemichael, MY; Wellmann, IA; Wen, A; Wild, D; Wilthoner, K; Winder, T; Wing, RR; Winget, M; Wöll, E; Wong, KL; Wong, KT; Wu, D; Wu, Q; Wu, Y; Xiang, T; Xiang, Z; Xu, F; Xu, L; Yamasaki, M; Yamashita, K; Yan, H; Yan, Y; Yang, C; Yang, H; Yang, J; Yang, N; Yang, Y; Yau, P; Yu, M; Yuan, Q; Zhan, S; Zhang, B; Zhang, H; Zhang, J; Zhang, N; Zhang, Y; Zhao, X; Zheng, BJ; Zheng, H; Zheng, W; Zhou, H; Zhou, X; Zhu, S; Zimmer, DP; Zionts, D; Zitella, A; Zlott, J; Zolfaghari, K; Zuo, D; Zur Loye, HC; Žuža, I | 1 |
| Aldawsari, FS; Baksh, S; Bhullar, KS; Dyck, JRB; Hubbard, BP; Kerek, E; Losch, R; Ou, J; Pandya, V; Salla, M; Thiesen, A; Velazquez-Martinez, C; Wong, YF | 1 |
| Dong, W; Ma, J; Qiu, T; Tang, M; Wang, Y; Zhang, X | 1 |
| Kwaśnik, P; Lemieszek, MK; Rzeski, W | 1 |
| Chen, QZ; He, BC; He, F; Huang, M; Li, Y; Liao, YP; Ren, WY; Shao, Y; Wang, H; Wang, J; Wu, K; Zeng, YH; Zhou, LY; Zhu, JH | 1 |
| Antonio, S; Auzeil, N; Barouki, R; Benelli, C; Bortoli, S; Coumoul, X; Huc, L; Laprévote, O; Regazzetti, A; Saunier, E; Shay, JW | 1 |
| Alcaide, A; Cercas, E; Motilva, V; Peiró, C; Ramos-González, M; Romero, A; San Hipólito-Luengo, Á; Sánchez-Ferrer, CF; Talero, E; Vallejo, S | 1 |
| Bennett, JA; Changou, CA; Chen, YR; Chin, YT; Davis, PJ; Fu, E; Ho, Y; Incerpi, S; Li, WS; Lin, CY; Lin, HY; Liu, LF; Mousa, SA; Nana, AW; Pedersen, JZ; Shih, YJ; Whang-Peng, J | 1 |
| Chadha, VD; Dhawan, DK; Kamal, R | 1 |
| Ball, MS; Bucio-Noble, D; Kautto, L; Krisp, C; Molloy, MP | 1 |
| Adunyah, SE; Huderson, AC; Niaz, MS; Ramesh, A; Rekha Devi, PV | 1 |
| Darzynkiewicz, Z; Halicka, HD; Hsieh, TC; Lucas, J; Wu, JM | 1 |
| Bie, L; Chen, B; Chen, X; Deng, W; Guo, Y; Guo, Z; Jin, G; Li, D; Li, N; Liu, Y; Luo, S; Wang, G; Yao, K; Zhao, Z | 1 |
| Abdelghany, AA; Al-Amoudi, HS; Efferth, T; Eid, S; El-Readi, MZ; Wink, M | 1 |
| Chen, Y; Deng, H; Huang, J; Tang, X; Wang, XJ; Zheng, Z | 1 |
| Cho, N; Choi, S; Kim, KK; Park, SH; Sa, M | 1 |
| Li, B; Li, F; Li, M; Li, Y; Wang, F; Yan, C; Zhang, G; Zhang, Y; Zhao, X | 1 |
| Ghazali, AR; Harun, Z | 1 |
| Aires, V; Cotte, AK; Delmas, D; Ghiringhelli, F; Latruffe, N; Limagne, E | 1 |
| Banerjee, N; Del Follo-Martinez, A; Li, X; Mertens-Talcott, S; Safe, S | 1 |
| Carew, MA; Carrington, S; Meira, LB; Modjtahedi, H; Polycarpou, E; Tyrrell, E | 1 |
| Akao, Y; Iwasaki, J; Kumazaki, M; Noguchi, S; Shinohara, H; Yamada, N; Yasui, Y | 1 |
| Amiri, F; Jeddi-Tehrani, M; Koohdani, F; Vafa, M; Zand, H; Zarnani, AH | 1 |
| Das, D; Kundu, CN; Mohapatra, P; Preet, R; Satapathy, SR | 1 |
| Chen, L; Deng, ZL; He, BC; Huang, J; Liu, Y; Liu, YZ; Luo, JY; Meng, ZJ; Sun, WJ; Wang, DX; Wang, X; Wu, K; Yang, JQ; Yin, LJ; Yuan, SX; Zuo, GW | 1 |
| Aires, V; Brassart, B; Carlier, A; Delmas, D; Limagne, E; Mandard, S; Martiny, L; Scagliarini, A; Solary, E; Tarpin, M | 1 |
| Marko, D; Schroeter, A | 1 |
| Castrogiovanni, C; Demoulin, B; Dumont, P; Hermant, M; Staudt, C | 1 |
| Fürst, R; Kiehl, A; Scherzberg, MC; Stark, H; Stein, J; Steinhilber, D; Ulrich-Rückert, S; Zivkovic, A | 1 |
| Holcombe, RF; Martinez, M; Planutiene, M; Planutis, K | 1 |
| Del Favero, G; Groh, IA; Marko, D; Pignitter, M; Schroeter, A; Schueller, K; Somoza, V | 1 |
| Bai, Y; Chen, QZ; He, BC; Li, Y; Ren, CM; Shao, Y; Sun, WJ; Wang, DX; Wu, K; Wu, QX; Yang, JQ; Yu, Y; Yuan, SX; Zeng, YH; Zhang, P | 1 |
| Feng, M; Huang, ZH; Xiong, JP; Zhan, ZY; Zhong, LX | 2 |
| Charepalli, V; Elias, RJ; Lambert, JD; Radhakrishnan, S; Reddivari, L; Vadde, R; Vanamala, JK | 1 |
| Blanquer-Rosselló, MD; Hernández-López, R; Oliver, J; Roca, P; Valle, A | 1 |
| Chung, HY; Jung, JH; Kim, DH; Kim, MJ; Kim, ND; Suh, H; Sung, B | 1 |
| Fang, Y; Liang, X; Liu, J; Qin, X; Wu, H; Zhang, Y | 1 |
| MacLachlan, TK | 1 |
| Deeptha, K; Nalini, N; Sengottuvelan, M | 2 |
| Basaran, A; Cosan, D; Degirmenci, I; Gunes, HV; Soyocak, A | 1 |
| Colin, D; Delmas, D; Gimazane, A; Izard, JC; Latruffe, N; Lizard, G; Solary, E | 1 |
| Chen, J; Dong, XS; Guo, XG | 1 |
| Ji, Y; Lee, HJ; Paul, S; Reddy, BS; Rimando, AM; Suh, N | 1 |
| Chan, JY; Lee, SC; Pervaiz, S | 1 |
| Chan, JY; Lee, SC; Tan, BK | 1 |
| Banerjee, S; Du, J; Elliott, AA; Levi, E; Majumdar, AP; Nautiyal, J; Patel, BB; Patel, V; Sarkar, FH; Yu, Y | 1 |
| Kim, MY; Trudel, LJ; Wogan, GN | 1 |
| Beyrath, J; Briand, JP; Fournel, S; Gronemeyer, H; Guichard, G; Lechner, MC; Maison, W; Micheau, O; Morizot, A; Pardin, C; Pavet, V; Wendland, M | 1 |
| Kundu, JK; Lee, JS; Na, HK; Surh, YJ; Youn, J | 1 |
| Chumanevich, A; Cui, X; Habiger, J; Hofseth, AB; Hofseth, LJ; Jin, Y; Nagarkatti, M; Nagarkatti, PS; Pena, E; Poudyal, D; Singh, UP | 1 |
| Birt, DF; Brummer, EC; Kineman, BD; Paiva, NL | 1 |
| Anant, S; Houchen, CW; Ramalingam, S; Subramaniam, D | 1 |
| Hofseth, LJ; Nagarkatti, M; Nagarkatti, PS; Singh, NP; Singh, UP | 1 |
| Radhakrishnan, S; Reddivari, L; Tarver, C; Vanamala, J | 1 |
| Alfaras, I; Juan, ME; Planas, JM | 1 |
| Basaran, A; Bayram, B; Cosan, DT; Degirmenci, I; Gunes, HV; Musmul, A; Soyocak, A | 1 |
| Brown, D; Davis, FB; Davis, PJ; Drusano, GL; Kulawy, R; Landersdorfer, CB; Lim, CU; Lin, C; Lin, HY; Lin, S; London, D; Louie, A; Meng, R; Mousa, SA; Queimado, L; Tang, HY; Van Scoy, B | 1 |
| Chiou, YS; Ho, CT; Nagabhushanam, K; Pan, MH; Tsai, ML; Wang, YJ; Wu, CH | 1 |
| Athias, A; Colin, D; Delmas, D; Gambert, P; Hichami, A; Jacquel, A; Jeanningros, S; Latruffe, N; Limagne, E; Lizard, G; Solary, E | 1 |
| Das, UN; Radhakrishnan, S; Reddivari, L; Sclafani, R; Vanamala, J | 1 |
| González-Sarrías, A; Gromek, S; Henry, GE; Niesen, D; Seeram, NP | 1 |
| Oliver, J; Roca, P; Santandreu, FM; Valle, A | 1 |
| Decker, EA; Dong, P; McClements, DJ; Nutakul, W; Qiu, P; Sobers, HS; Xiao, H | 1 |
| Kimura, A; Miki, H; Sasaki, T; Tsubura, A; Uehara, N; Yoshizawa, K; Yuri, T | 1 |
| Acquafredda, A; Carofiglio, V; Cavallo, P; Cianciulli, A; Panaro, MA | 1 |
| Lee, JH; Park, JW; Tak, JK | 1 |
| Huderson, AC; Myers, JN; Niaz, MS; Ramesh, A; Washington, MK | 1 |
| Chen, HJ; Hsu, LS; Lin, CM; Lin, MW; Shia, YT | 1 |
| Bergman, M; Bessler, H; Djaldetti, M; Levin, GS; Salman, H | 1 |
| Drew, DA; Ménoret, A; Miyamoto, S; Nakanishi, M; Rosenberg, DW; Vella, AT | 1 |
| Ermakova, SP; Vishchuk, OS; Zvyagintseva, TN | 1 |
| Berlot, JP; Cherkaoui Malki, M; Delmas, D; Jannin, B; Latruffe, N; Passilly-Degrace, P | 1 |
| Chen, L; Liang, YC; Lin, JK; Lin-Shiau, SY; Tsai, SH | 1 |
| Stein, J; Turchanowa, L; Wolter, F | 1 |
| Hoe, YH; Kim, EY; Kim, S; Ko, H; Lee, SK; Lee, T; Min, HY; Nam, KA; Song, S | 1 |
| Akao, Y; Iinuma, M; Ito, T; Matsumoto, K; Nozawa, Y; Ohguchi, K; Tanaka, T; Yi, H | 1 |
| Athias, A; Cherkaoui-Malki, M; Delmas, D; Dubrez-Daloz, L; Filomenko, R; Gambert, P; Jannin, B; Lacour, S; Latruffe, N; Rébé, C; Solary, E | 1 |
| Brouillard, R; Chabert, P; Coelho, D; Fougerousse, A; Gossé, F; Launay, JF; Raul, F; Schneider, Y; Stutzmann, J | 1 |
| Athias, A; Delmas, D; Gambert, P; Grazide, S; Latruffe, N; Laurent, G; Micheau, O; Rébé, C; Solary, E | 1 |
| Gescher, AJ; Potter, GA; Ruparelia, KC; Sale, S; Steward, WP; Tunstall, RG | 1 |
| Mousa, SA; Mousa, SS | 1 |
| Nalini, N; Sengottuvelan, M; Viswanathan, P | 1 |
| Chan, J; Clement, MV; Lee, SC; Pervaiz, S | 1 |
| Bhavya, BC; Gandhi, AA; Indu, R; Karunagaran, D; Mohan, J; Rashmi, R; Santhoshkumar, TR | 1 |
| Brüne, B; Loitsch, SM; Rau, O; Schubert-Zsilavecz, M; Stein, JM; Ulrich, S; von Knethen, A | 1 |
| Nalini, N; Sengottuvelan, M | 1 |
| Bonmassar, E; Cottarelli, A; Falchetti, R; Fuggetta, MP; Lanzilli, G; Ravagnan, G; Tricarico, M | 1 |
| Brouillard, R; Chabert, P; Fougerousse, A | 1 |
| Jeong, YJ; Kwon, TK; Lee, JM; Lee, SH; Lee, TJ; Park, JW; Seo, JH; Woo, KJ | 1 |
| Wietrzyk, J | 1 |
| Au, A; Birt, DF; Brummer, EC; Kaiser, MS; Kineman, BD; Paiva, NL | 1 |
| Choi, YH; Kim, SH; Kwon, TK; Lee, JT; Lee, TJ; Lim, JH; Park, JW; Woo, KJ | 1 |
| Delmas, D; Izard, JC; Latruffe, N; Lizard, G; Marel, AK | 1 |
| Chan, JY; Clement, MV; Lee, SC; Pervaiz, S; Phoo, MS | 1 |
| Hanson, JA; Holcombe, RF; Hope, C; Johal, KS; Moyer, MP; Planutiene, M; Planutis, K; Santoso, C; Woo, J | 1 |
| Badolo, L; Bergmann, C; Duranton, B; Gossé, F; Raul, F; Schneider, Y; Seiler, N; Vincent, F | 1 |
| Mahyar-Roemer, M; Roemer, K | 1 |
| Diamandis, EP; Goldberg, DM; Grass, L; Levesque, M; Soleas, GJ | 1 |
| Katsen, A; Mahyar-Roemer, M; Mestres, P; Roemer, K | 1 |
| Akao, Y; Iinuma, M; Ito, T; Nozawa, Y; Tanaka, T | 1 |
| Stein, J; Wolter, F | 1 |
2 review(s) available for resveratrol and Cancer of Colon
| Article | Year |
|---|---|
Cancer stem cells: a novel paradigm for cancer prevention and treatment.
Topics: AC133 Antigen; Antigens, CD; Breast Neoplasms; Colonic Neoplasms; Curcumin; Female; Glycoproteins; Hedgehog Proteins; Humans; Neoplastic Stem Cells; Pancreatic Neoplasms; Peptides; Protein Serine-Threonine Kinases; Receptors, Notch; Resveratrol; Signal Transduction; Stilbenes | 2010 |
[The influence of isoflavonoids on the antitumor activity of vitamin D3].
Topics: 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Cholecalciferol; Colonic Neoplasms; Female; Humans; Isoflavones; Male; Mice; Prostatic Neoplasms; Receptors, Calcitriol; Resveratrol; Steroid Hydroxylases; Stilbenes; Tumor Cells, Cultured; Up-Regulation; Vitamin D3 24-Hydroxylase | 2007 |
1 trial(s) available for resveratrol and Cancer of Colon
112 other study(ies) available for resveratrol and Cancer of Colon
| Article | Year |
|---|---|
In vitro and in vivo studies on stilbene analogs as potential treatment agents for colon cancer.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Female; Humans; Mice; Proliferating Cell Nuclear Antigen; Stilbenes; Tumor Burden; Xenograft Model Antitumor Assays | 2010 |
Fluorinated N,N-dialkylaminostilbenes for Wnt pathway inhibition and colon cancer repression.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drug Screening Assays, Antitumor; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Resveratrol; Signal Transduction; Stereoisomerism; Stilbenes; Structure-Activity Relationship; Transplantation, Heterologous; Wnt Proteins | 2011 |
The Aneugenicity of Ketone Bodies in Colon Epithelial Cells Is Mediated by Microtubule Hyperacetylation and Is Blocked by Resveratrol.
Topics: Acetylation; Aneugens; Animals; Antioxidants; Cells, Cultured; Colon; Colonic Neoplasms; Epithelial Cells; Fibroblasts; Humans; Ketone Bodies; Microtubules; Rats; Resveratrol | 2021 |
Inhibiting endoplasmic reticulum stress mediated-autophagy enhances the pro-apoptotic effects of resveratrol derivative in colon cancer cells.
Topics: Apoptosis; Autophagy; Colonic Neoplasms; Endoplasmic Reticulum Stress; Humans; Resveratrol | 2021 |
Combination of resveratrol and BIBR1532 inhibits proliferation of colon cancer cells by repressing expression of LncRNAs.
Topics: Aminobenzoates; Apoptosis; Cell Proliferation; Colonic Neoplasms; Down-Regulation; HT29 Cells; Humans; Naphthalenes; Resveratrol; RNA, Long Noncoding | 2021 |
Alpha-mangostin and resveratrol, dual-drugs-loaded mucoadhesive thiolated chitosan-based nanoparticles for synergistic activity against colon cancer cells.
Topics: Chitosan; Colonic Neoplasms; Drug Carriers; Humans; Nanoparticles; Particle Size; Resveratrol; Xanthones | 2022 |
Resveratrol inhibits proliferation and induces apoptosis via the Hippo/YAP pathway in human colon cancer cells.
Topics: Apoptosis; Cell Proliferation; Colonic Neoplasms; Humans; Molecular Docking Simulation; Protein Serine-Threonine Kinases; Resveratrol; Verteporfin | 2022 |
Resveratrol downregulates ENaCs through the activation of AMPK in human colon cancer cells.
Topics: Amiloride; AMP-Activated Protein Kinases; Apoptosis; Colonic Neoplasms; Epithelial Sodium Channels; Humans; Resveratrol | 2023 |
Design, synthesis and anti-tumor efficacy evaluation of novel 1,3-diaryl propane-based polyphenols obtained from Claisen rearrangement reaction.
Topics: Animals; Biological Products; Colonic Neoplasms; Disease Models, Animal; Mice; Polyphenols; Propane; Resveratrol | 2023 |
Improvement of the Physicochemical Limitations of Rhapontigenin, a Cytotoxic Analogue of Resveratrol against Colon Cancer.
Topics: Antineoplastic Agents; Colonic Neoplasms; Cyclodextrins; Humans; Resveratrol; Stilbenes | 2023 |
Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial‑ mesenchymal transition via the AKT/GSK‑3β/Snail signaling pathway.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Colonic Neoplasms; Disease Models, Animal; Epithelial-Mesenchymal Transition; Glycogen Synthase Kinase 3 beta; Humans; Immunohistochemistry; Male; Mice; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Snail Family Transcription Factors; Xenograft Model Antitumor Assays | 2019 |
Targeted delivery and apoptosis induction of trans-resveratrol-ferulic acid loaded chitosan coated folic acid conjugate solid lipid nanoparticles in colon cancer cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Chitosan; Colonic Neoplasms; Coumaric Acids; Drug Delivery Systems; Drug Liberation; Humans; Lipids; Nanoparticles; Resveratrol | 2020 |
Resveratrol and Resveratrol-Aspirin Hybrid Compounds as Potent Intestinal Anti-Inflammatory and Anti-Tumor Drugs.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Aspirin; Colonic Neoplasms; Enzyme Inhibitors; HCT116 Cells; Humans; Mice; Neoplasm Proteins; Resveratrol | 2020 |
In vitro and in vivo combinatorial anticancer effects of oxaliplatin- and resveratrol-loaded N,O-carboxymethyl chitosan nanoparticles against colorectal cancer.
Topics: Chitosan; Colonic Neoplasms; Drug Carriers; Humans; Nanoparticles; Oxaliplatin; Resveratrol | 2021 |
Impact of phytochemicals and plant extracts on viability and proliferation of NK cell line NK-92 - a closer look at immunomodulatory properties of goji berries extract in human colon cancer cells.
Topics: Cell Line, Tumor; Cell Proliferation; Chlorella; Colonic Neoplasms; Curcumin; Fruit; Humans; Immunologic Factors; Killer Cells, Natural; Lycium; Phytochemicals; Plant Extracts; Resveratrol | 2021 |
Resveratrol inactivates PI3K/Akt signaling through upregulating BMP7 in human colon cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Bone Morphogenetic Protein 7; Cell Proliferation; Cell Survival; Colonic Neoplasms; Flow Cytometry; HCT116 Cells; Humans; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Resveratrol; Signal Transduction; Stilbenes; Up-Regulation | 2017 |
Resveratrol reverses the Warburg effect by targeting the pyruvate dehydrogenase complex in colon cancer cells.
Topics: Biological Availability; Caco-2 Cells; Calcium Signaling; Cell Proliferation; Cell Survival; Colonic Neoplasms; Gene Expression Regulation, Neoplastic; Glycolysis; HCT116 Cells; Humans; Lipid Metabolism; Pyruvate Dehydrogenase Complex; Resveratrol | 2017 |
Dual Effects of Resveratrol on Cell Death and Proliferation of Colon Cancer Cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Death; Cell Proliferation; Colonic Neoplasms; DNA Damage; Dose-Response Relationship, Drug; HCT116 Cells; HT29 Cells; Humans; L-Lactate Dehydrogenase; Quercetin; Reactive Oxygen Species; Resveratrol; Sirtuins; Stilbenes; Superoxides | 2017 |
Tetrac downregulates β-catenin and HMGA2 to promote the effect of resveratrol in colon cancer.
Topics: Animals; Antineoplastic Agents; beta Catenin; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Down-Regulation; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; HMGA2 Protein; Humans; Mice, Nude; Resveratrol; Thyroxine | 2018 |
Physiological uptake and retention of radiolabeled resveratrol loaded gold nanoparticles (
Topics: Animals; Antineoplastic Agents, Phytogenic; Biological Transport; Cell Proliferation; Colonic Neoplasms; Gold; Male; Metal Nanoparticles; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Resveratrol; Technetium Tc 99m Pentetate; Tissue Distribution; Tumor Cells, Cultured | 2018 |
Polyphenol extracts from dried sugarcane inhibit inflammatory mediators in an in vitro colon cancer model.
Topics: Anti-Inflammatory Agents; Cell Line, Tumor; Colonic Neoplasms; Humans; Inflammation Mediators; Interleukin-8; Mass Spectrometry; NF-kappa B; Oxidative Stress; Phosphoproteins; Plant Extracts; Polyphenols; Proteome; Resveratrol; Saccharum | 2018 |
Alteration of benzo(a)pyrene biotransformation by resveratrol in Apc
Topics: Animals; Antioxidants; Apoptosis; Benzo(a)pyrene; Biotransformation; Carcinogenesis; Carcinogens, Environmental; Cell Proliferation; Colonic Neoplasms; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; Disease Models, Animal; DNA Adducts; Gene Expression Regulation, Neoplastic; Glutathione Transferase; Humans; Male; Mice; Resveratrol; Tissue Distribution; Tumor Cells, Cultured | 2019 |
Upregulation of PD‑L1 expression by resveratrol and piceatannol in breast and colorectal cancer cells occurs via HDAC3/p300‑mediated NF‑κB signaling.
Topics: Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; E1A-Associated p300 Protein; Female; G1 Phase Cell Cycle Checkpoints; Histone Deacetylases; Humans; NF-kappa B; Programmed Cell Death 1 Receptor; Resveratrol; Signal Transduction; Stilbenes; Treatment Outcome; Triple Negative Breast Neoplasms; Up-Regulation | 2018 |
Resveratrol suppresses colon cancer growth by targeting the AKT/STAT3 signaling pathway.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; G1 Phase Cell Cycle Checkpoints; Gene Knockdown Techniques; Humans; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; STAT3 Transcription Factor; Tumor Stem Cell Assay | 2019 |
Resveratrol mediated cancer cell apoptosis, and modulation of multidrug resistance proteins and metabolic enzymes.
Topics: Apoptosis; Caco-2 Cells; Cell Line, Tumor; Colonic Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Humans; Multidrug Resistance-Associated Proteins; Plant Extracts; Resveratrol | 2019 |
Mkp-1 is required for chemopreventive activity of butylated hydroxyanisole and resveratrol against colitis-associated colon tumorigenesis.
Topics: Animals; Anticarcinogenic Agents; Butylated Hydroxyanisole; Cell Transformation, Neoplastic; Colitis; Colonic Neoplasms; Dual Specificity Phosphatase 1; Mice, Inbred BALB C; Mice, Knockout; NF-E2-Related Factor 2; Real-Time Polymerase Chain Reaction; Resveratrol; Signal Transduction | 2019 |
Rbfox2 dissociation from stress granules suppresses cancer progression.
Topics: Animals; Cell Cycle; Colonic Neoplasms; Flow Cytometry; HeLa Cells; Humans; Immunoprecipitation; Male; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Resveratrol; Retinoblastoma Binding Proteins; RNA Splicing Factors; Ubiquitin-Protein Ligases | 2019 |
Effects of As2O3 and Resveratrol on the Proliferation and Apoptosis of Colon Cancer Cells and the hERG-mediated Potential Mechanisms.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Humans; Oxides; Resveratrol; Signal Transduction; Transcriptional Regulator ERG | 2019 |
Potential chemoprevention activity of pterostilbene by enhancing the detoxifying enzymes in the HT-29 cell line.
Topics: Cell Line, Tumor; Chemoprevention; Colonic Neoplasms; Glutathione; Glutathione Transferase; HT29 Cells; Humans; Inactivation, Metabolic; NAD(P)H Dehydrogenase (Quinone); Resveratrol; Stilbenes | 2012 |
Resveratrol metabolites inhibit human metastatic colon cancer cells progression and synergize with chemotherapeutic drugs to induce cell death.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Drug Synergism; Glucuronides; Humans; Resveratrol; Stilbenes | 2013 |
Resveratrol and quercetin in combination have anticancer activity in colon cancer cells and repress oncogenic microRNA-27a.
Topics: Antineoplastic Agents, Phytogenic; Caspase 3; Cell Cycle; Cell Proliferation; Colonic Neoplasms; Down-Regulation; Enzyme Activation; HT29 Cells; Humans; Kinetics; MicroRNAs; Quercetin; Reactive Oxygen Species; Resveratrol; Sp1 Transcription Factor; Sp3 Transcription Factor; Sp4 Transcription Factor; Stilbenes | 2013 |
Resveratrol 3-O-D-glucuronide and resveratrol 4'-O-D-glucuronide inhibit colon cancer cell growth: evidence for a role of A3 adenosine receptors, cyclin D1 depletion, and G1 cell cycle arrest.
Topics: Adenosine A3 Receptor Antagonists; AMP-Activated Protein Kinases; Apoptosis; Caco-2 Cells; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Cyclin D1; G1 Phase Cell Cycle Checkpoints; Glucuronides; Hemolysis; Humans; Receptor, Adenosine A3; Resveratrol; Stilbenes | 2013 |
Anti-cancer effects of naturally occurring compounds through modulation of signal transduction and miRNA expression in human colon cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Catechin; Cell Line, Tumor; Colonic Neoplasms; Drug Resistance, Neoplasm; Humans; MicroRNAs; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphatidylinositol 3-Kinases; Resveratrol; Signal Transduction; Stilbenes; Xanthones | 2013 |
Synergistic anti-proliferative effect of resveratrol and etoposide on human hepatocellular and colon cancer cell lines.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drug Synergism; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Resveratrol; Stilbenes; Tumor Suppressor Protein p53 | 2013 |
1,3-Bis(2-chloroethyl)-1-nitrosourea enhances the inhibitory effect of resveratrol on 5-fluorouracil sensitive/resistant colon cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Carmustine; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; Colonic Neoplasms; DNA Damage; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Fluorouracil; HCT116 Cells; Humans; Resveratrol; Stilbenes | 2013 |
The PTEN/PI3K/Akt and Wnt/β-catenin signaling pathways are involved in the inhibitory effect of resveratrol on human colon cancer cell proliferation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Colonic Neoplasms; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Mice; Mice, Nude; Neoplasms, Experimental; PTEN Phosphohydrolase; Resveratrol; Signal Transduction; Stilbenes; Xenograft Model Antitumor Assays | 2014 |
A role for peroxisome proliferator-activated receptor gamma in resveratrol-induced colon cancer cell apoptosis.
Topics: Anilides; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Humans; PPAR gamma; Resveratrol; Rosiglitazone; S Phase Cell Cycle Checkpoints; Stilbenes; Thiazolidinediones | 2014 |
Resveratrol modulates the topoisomerase inhibitory potential of doxorubicin in human colon carcinoma cells.
Topics: Cell Death; Cell Proliferation; Colonic Neoplasms; DNA Damage; DNA, Neoplasm; Doxorubicin; HT29 Cells; Humans; Intracellular Space; Resveratrol; Rhodamines; Stilbenes; Topoisomerase Inhibitors | 2014 |
Resveratrol induces DNA damage in colon cancer cells by poisoning topoisomerase II and activates the ATM kinase to trigger p53-dependent apoptosis.
Topics: Apoptosis; Ataxia Telangiectasia Mutated Proteins; Colonic Neoplasms; DNA Damage; DNA Topoisomerases, Type II; HCT116 Cells; Humans; Mitogen-Activated Protein Kinase Kinases; Resveratrol; Stilbenes; Tumor Suppressor Protein p53 | 2015 |
Structural modification of resveratrol leads to increased anti-tumor activity, but causes profound changes in the mode of action.
Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Caco-2 Cells; Cell Cycle Checkpoints; Cell Proliferation; Colonic Neoplasms; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Hep G2 Cells; HT29 Cells; Humans; Liver Neoplasms; Microtubules; Molecular Structure; Resveratrol; RNA Interference; Sirtuin 1; Stilbenes; Structure-Activity Relationship; Transfection; Tubulin Modulators | 2015 |
Effects of a grape-supplemented diet on proliferation and Wnt signaling in the colonic mucosa are greatest for those over age 50 and with high arginine consumption.
Topics: AC133 Antigen; Adolescent; Adult; Antigens, CD; Arginine; Axin Protein; Biomarkers; Body Mass Index; Cell Proliferation; Colon; Colonic Neoplasms; Cyclin D1; Diet; Female; Glycoproteins; Humans; Intestinal Mucosa; Linear Models; Male; Mental Recall; Middle Aged; Peptides; Proto-Oncogene Proteins c-myc; Resveratrol; Stilbenes; Vitis; Wnt Signaling Pathway; Young Adult | 2015 |
Inhibition of topoisomerase II by phase II metabolites of resveratrol in human colon cancer cells.
Topics: Apoptosis; Caco-2 Cells; Cell-Free System; Colonic Neoplasms; Comet Assay; Drug Screening Assays, Antitumor; Glucuronides; HT29 Cells; Humans; Resveratrol; Stilbenes; Topoisomerase II Inhibitors | 2015 |
BMP9/p38 MAPK is essential for the antiproliferative effect of resveratrol on human colon cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Flow Cytometry; Growth Differentiation Factor 2; Growth Differentiation Factors; Humans; Immunohistochemistry; Mice; Mice, Nude; p38 Mitogen-Activated Protein Kinases; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes; Xenograft Model Antitumor Assays | 2016 |
Resveratrol Treatment Inhibits Proliferation of and Induces Apoptosis in Human Colon Cancer Cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Humans; Indomethacin; Receptors, Prostaglandin; Resveratrol; Stilbenes | 2016 |
Grape compounds suppress colon cancer stem cells in vitro and in a rodent model of colon carcinogenesis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; beta Catenin; Cell Proliferation; Colonic Neoplasms; Disease Models, Animal; Grape Seed Extract; Male; Mice; Neoplastic Stem Cells; Resveratrol; Signal Transduction; Stilbenes; Vitis | 2016 |
Resveratrol induces mitochondrial respiration and apoptosis in SW620 colon cancer cells.
Topics: Adenosine Triphosphate; Apoptosis; Caloric Restriction; Cell Line, Tumor; Cell Respiration; Colon; Colonic Neoplasms; Energy Metabolism; Fatty Acids; Glycolysis; Humans; Mitochondria; Mitochondrial Membranes; Oxidation-Reduction; Oxidative Phosphorylation; Oxygen Consumption; Reactive Oxygen Species; Resveratrol; Stilbenes | 2017 |
Resveratrol analogue, HS-1793, induces apoptotic cell death and cell cycle arrest through downregulation of AKT in human colon cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Chromones; Colonic Neoplasms; Cytochromes c; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; HCT116 Cells; Humans; Morpholines; Naphthols; Phosphorylation; Proto-Oncogene Proteins c-akt; Resorcinols; Resveratrol; Stilbenes | 2017 |
Enhanced antitumor efficacy of resveratrol-loaded nanocapsules in colon cancer cells: physicochemical and biological characterization.
Topics: Antineoplastic Agents; Apoptosis; Colonic Neoplasms; Drug Carriers; HT29 Cells; Humans; Lipids; Nanocapsules; Resveratrol; Stilbenes | 2017 |
Resveratrol inhibits hypoxia-induced metastasis potential enhancement by restricting hypoxia-induced factor-1 alpha expression in colon carcinoma cells.
Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Cell Adhesion; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Cell Survival; Colonic Neoplasms; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neoplasm Metastasis; Resveratrol; RNA, Messenger; Stilbenes; Vascular Endothelial Growth Factor A | 2008 |
In vino, curationis?
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluorouracil; HCT116 Cells; Humans; Resveratrol; Sirtuins; Stilbenes; Wine | 2008 |
Resveratrol attenuates 1,2-dimethylhydrazine (DMH) induced glycoconjugate abnormalities during various stages of colon carcinogenesis.
Topics: 1,2-Dimethylhydrazine; Animals; Antineoplastic Agents, Phytogenic; Colonic Neoplasms; Disease Models, Animal; Fucose; Glycoconjugates; Hexosamines; Male; Rats; Rats, Wistar; Resveratrol; Sialic Acids; Stilbenes | 2009 |
The effects of resveratrol and tannic acid on apoptosis in colon adenocarcinoma cell line.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; Cell Line, Tumor; Colonic Neoplasms; Fas-Associated Death Domain Protein; Humans; Resveratrol; Stilbenes; Tannins | 2009 |
Effects of resveratrol analogs on cell cycle progression, cell cycle associated proteins and 5fluoro-uracil sensitivity in human derived colon cancer cells.
Topics: Antimetabolites, Antineoplastic; Benzofurans; Blotting, Western; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; Colonic Neoplasms; Drug Synergism; Flow Cytometry; Fluorescent Antibody Technique; Fluorouracil; Humans; Immunoenzyme Techniques; Immunoprecipitation; Phenols; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2009 |
Resveratrol ameliorates DNA damage, prooxidant and antioxidant imbalance in 1,2-dimethylhydrazine induced rat colon carcinogenesis.
Topics: 1,2-Dimethylhydrazine; Animals; Antioxidants; Carcinogens; Colonic Neoplasms; Comet Assay; DNA Damage; Dose-Response Relationship, Drug; Lipid Peroxidation; Male; Rats; Rats, Wistar; Reactive Oxygen Species; Resveratrol; Stilbenes | 2009 |
[Inhibitory effect of resveratrol on the growth of human colon cancer ls174t cells and its subcutaneously transplanted tumor in nude mice and the mechanism of action].
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Proto-Oncogene Proteins c-bcl-2; Resveratrol; RNA, Messenger; Stilbenes; Tumor Burden | 2009 |
Anti-inflammatory action of pterostilbene is mediated through the p38 mitogen-activated protein kinase pathway in colon cancer cells.
Topics: Anti-Inflammatory Agents; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclooxygenase 2; Cytokines; Humans; Inflammation; MAP Kinase Signaling System; Microscopy, Fluorescence; p38 Mitogen-Activated Protein Kinases; Poly(ADP-ribose) Polymerases; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes | 2009 |
Spontaneous and 5-fluorouracil-induced centrosome amplification lowers the threshold to resveratrol-evoked apoptosis in colon cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 6; Centrosome; Colonic Neoplasms; Dose-Response Relationship, Drug; Enzyme Activation; Fluorouracil; HCT116 Cells; Humans; Resveratrol; Stilbenes; Tumor Suppressor Protein p53; Up-Regulation | 2010 |
Scutellarin sensitizes drug-evoked colon cancer cell apoptosis through enhanced caspase-6 activation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apigenin; Apoptosis; Blotting, Western; Caspase 6; Colonic Neoplasms; Drug Therapy, Combination; Enzyme Activation; Fluorouracil; Glucuronates; Humans; Resveratrol; Stilbenes; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2009 |
Curcumin synergizes with resveratrol to inhibit colon cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Body Weight; Cell Cycle; Cell Nucleus; Cell Proliferation; Cell Survival; Colonic Neoplasms; Curcumin; Dose-Response Relationship, Drug; Drug Synergism; Female; HCT116 Cells; Humans; Mice; Mice, SCID; NF-kappa B; Nuclear Proteins; Phosphorylation; Receptors, Growth Factor; Resveratrol; Software; Stilbenes; Tumor Burden; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2009 |
Apoptosis induced by capsaicin and resveratrol in colon carcinoma cells requires nitric oxide production and caspase activation.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Arginine; Capsaicin; Caspase 3; Caspase 9; Colonic Neoplasms; Cytochromes c; Dose-Response Relationship, Drug; Enzyme Activation; Flow Cytometry; HCT116 Cells; Humans; Isoenzymes; Nitric Oxide; Nitric Oxide Synthase; Nucleosomes; Resveratrol; Stilbenes; Tumor Suppressor Protein p53 | 2009 |
Multivalent DR5 peptides activate the TRAIL death pathway and exert tumoricidal activity.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Line; Cells, Cultured; Colonic Neoplasms; Drug Synergism; Female; HCT116 Cells; Humans; Mice; Mice, Nude; Molecular Sequence Data; Oligopeptides; Receptors, TNF-Related Apoptosis-Inducing Ligand; Resveratrol; Signal Transduction; Stilbenes; Surface Plasmon Resonance; TNF-Related Apoptosis-Inducing Ligand; Tumor Burden; Xenograft Model Antitumor Assays | 2010 |
Resveratrol and piceatannol inhibit iNOS expression and NF-kappaB activation in dextran sulfate sodium-induced mouse colitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Colonic Neoplasms; Dextran Sulfate; DNA-Binding Proteins; Down-Regulation; Drug Therapy, Combination; Extracellular Signal-Regulated MAP Kinases; I-kappa B Kinase; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred ICR; NF-kappa B; Nitric Oxide Synthase Type II; Phosphorylation; Resveratrol; STAT3 Transcription Factor; Stilbenes; Time Factors | 2009 |
Resveratrol suppresses colitis and colon cancer associated with colitis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinogens; Cell Separation; Colitis; Colonic Neoplasms; Female; Flow Cytometry; Immunohistochemistry; Inflammation; Male; Mice; Mice, Inbred C57BL; Precancerous Conditions; Resveratrol; Stilbenes; T-Lymphocytes | 2010 |
Resveratrol from transgenic alfalfa for prevention of aberrant crypt foci in mice.
Topics: Animals; Azoxymethane; Body Weight; Chromatography, High Pressure Liquid; Colonic Neoplasms; Eating; Female; Glucosides; Lactase-Phlorizin Hydrolase; Medicago sativa; Mice; Plants, Genetically Modified; Precancerous Conditions; Resveratrol; Stilbenes | 2010 |
Taming the beast within: resveratrol suppresses colitis and prevents colon cancer.
Topics: Aging; Animals; Colitis; Colonic Neoplasms; Humans; Inflammation Mediators; Mice; NF-kappa B; Resveratrol; Sirtuin 1; Stilbenes | 2010 |
Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Proliferation; Colonic Neoplasms; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Dose-Response Relationship, Drug; Forkhead Box Protein O3; Forkhead Transcription Factors; HT29 Cells; Humans; Insulin-Like Growth Factor I; Intracellular Signaling Peptides and Proteins; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Resveratrol; RNA Interference; Signal Transduction; Stilbenes; Time Factors; Tumor Suppressor Protein p53; Wnt Proteins | 2010 |
trans-Resveratrol reduces precancerous colonic lesions in dimethylhydrazine-treated rats.
Topics: 1,2-Dimethylhydrazine; Animals; Colon; Colonic Neoplasms; Disease Models, Animal; Humans; Male; Precancerous Conditions; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2010 |
Role of phenolic compounds in nitric oxide synthase activity in colon and breast adenocarcinoma.
Topics: Adenocarcinoma; Anticarcinogenic Agents; Breast Neoplasms; Caco-2 Cells; Cell Line, Tumor; Chemoprevention; Colonic Neoplasms; Female; Humans; Nitric Oxide Synthase; Phenols; Resveratrol; Stilbenes; Tannins | 2010 |
Pharmacodynamic modeling of anti-cancer activity of tetraiodothyroacetic acid in a perfused cell culture system.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cetuximab; Colonic Neoplasms; Computational Biology; Drug Therapy, Combination; Female; Humans; Models, Biological; Monte Carlo Method; Nanoparticles; Resveratrol; Stilbenes; Thyroxine | 2011 |
Pterostilbene is more potent than resveratrol in preventing azoxymethane (AOM)-induced colon tumorigenesis via activation of the NF-E2-related factor 2 (Nrf2)-mediated antioxidant signaling pathway.
Topics: Animals; Antioxidants; Azoxymethane; Colonic Neoplasms; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Inbred BALB C; NF-E2-Related Factor 2; Resveratrol; Signal Transduction; Stilbenes | 2011 |
Endocytosis of resveratrol via lipid rafts and activation of downstream signaling pathways in cancer cells.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Apoptosis; beta-Cyclodextrins; Blotting, Western; Colonic Neoplasms; Endocytosis; Extracellular Signal-Regulated MAP Kinases; Filipin; Flow Cytometry; Focal Adhesion Kinase 1; GRB2 Adaptor Protein; Humans; Immunoenzyme Techniques; Immunoprecipitation; Integrin alphaVbeta3; Membrane Microdomains; Nystatin; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-fyn; ras Proteins; Resveratrol; Signal Transduction; Son of Sevenless Proteins; Stilbenes; Tumor Cells, Cultured | 2011 |
Resveratrol potentiates grape seed extract induced human colon cancer cell apoptosis.
Topics: Apoptosis; Cell Line, Tumor; Cell Separation; Chromatography, Liquid; Colonic Neoplasms; Flow Cytometry; Humans; Mass Spectrometry; Plant Extracts; Resveratrol; Seeds; Stilbenes | 2011 |
Resveratrol oligomers isolated from Carex species inhibit growth of human colon tumorigenic cells mediated by cell cycle arrest.
Topics: Caco-2 Cells; Carex Plant; Cell Cycle Checkpoints; Cell Division; Colon; Colonic Neoplasms; HCT116 Cells; HT29 Cells; Humans; Resveratrol; Stilbenes | 2011 |
Resveratrol potentiates the cytotoxic oxidative stress induced by chemotherapy in human colon cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Fluorouracil; Humans; Lipid Peroxidation; Oxidative Stress; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Resveratrol; STAT3 Transcription Factor; Stilbenes | 2011 |
Inhibitory effects of resveratrol and pterostilbene on human colon cancer cells: a side-by-side comparison.
Topics: Annexin A5; Antineoplastic Agents; Apoptosis; Caco-2 Cells; Cell Survival; Colonic Neoplasms; HCT116 Cells; HT29 Cells; Humans; Resveratrol; Stilbenes | 2011 |
Resveratrol induces apoptosis via ROS-triggered autophagy in human colon cancer cells.
Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Caspase 3; Caspase 8; Cell Growth Processes; Cell Line, Tumor; Colonic Neoplasms; HT29 Cells; Humans; Oligopeptides; Reactive Oxygen Species; Resveratrol; Signal Transduction; Stilbenes | 2012 |
Anti-inflammatory effects of resveratrol occur via inhibition of lipopolysaccharide-induced NF-κB activation in Caco-2 and SW480 human colon cancer cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Caco-2 Cells; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Dietary Supplements; Down-Regulation; Enterocytes; Humans; I-kappa B Proteins; Inflammatory Bowel Diseases; Lipopolysaccharides; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Phosphorylation; Protein Processing, Post-Translational; Proteolysis; Resveratrol; RNA, Messenger; Stilbenes; Toll-Like Receptor 4 | 2012 |
Resveratrol and piperine enhance radiosensitivity of tumor cells.
Topics: Alkaloids; Anticarcinogenic Agents; Apoptosis; Benzodioxoles; Blotting, Western; Colonic Neoplasms; Humans; Melanoma, Experimental; Membrane Potential, Mitochondrial; Oxidation-Reduction; Piper nigrum; Piperidines; Polyunsaturated Alkamides; Radiation Tolerance; Radiation-Sensitizing Agents; Radiation, Ionizing; Reactive Oxygen Species; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2012 |
Chemoprevention of benzo(a)pyrene-induced colon polyps in ApcMin mice by resveratrol.
Topics: Adenocarcinoma; Animals; Apoptosis; Benzo(a)pyrene; Cell Cycle; Colonic Neoplasms; Colonic Polyps; Male; Mice; Resveratrol; Stilbenes | 2013 |
The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway.
Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; beta Catenin; Cell Line; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Colonic Neoplasms; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Protein Binding; Resveratrol; Signal Transduction; Stilbenes; TCF Transcription Factors; Transcription Factor 4; Transcription Factors; Transcription, Genetic; Wnt Proteins | 2012 |
Resveratrol affects the cross talk between immune and colon cancer cells.
Topics: Adult; Cell Line, Tumor; Colonic Neoplasms; Cytokines; Dose-Response Relationship, Drug; HT29 Cells; Humans; Interleukins; Leukocytes, Mononuclear; Resveratrol; Stilbenes; Tumor Necrosis Factor-alpha | 2013 |
Differential proteomics identifies PDIA3 as a novel chemoprevention target in human colon cancer cells.
Topics: Anticarcinogenic Agents; Biomarkers, Tumor; Blotting, Western; Colonic Neoplasms; Electrophoresis, Gel, Two-Dimensional; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Immunoprecipitation; Protein Disulfide-Isomerases; Proteomics; Resveratrol; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Stilbenes; Tumor Cells, Cultured | 2014 |
The effect of sulfated (1→3)-α-l-fucan from the brown alga Saccharina cichorioides Miyabe on resveratrol-induced apoptosis in colon carcinoma Cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma; Caspases; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; HCT116 Cells; Humans; Magnetic Resonance Spectroscopy; Phaeophyceae; Polysaccharides; Resveratrol; Stilbenes; Sulfuric Acid Esters | 2013 |
Molecular analysis on the chemopreventive properties of resveratrol, a plant polyphenol microcomponent.
Topics: Antineoplastic Agents, Phytogenic; Cell Division; Colonic Neoplasms; Flow Cytometry; Genistein; Hepatoblastoma; Humans; In Vitro Techniques; Neoplasms; Resveratrol; S Phase; Stilbenes; Tumor Cells, Cultured | 2002 |
Resveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells.
Topics: Antineoplastic Agents; cdc25 Phosphatases; Cell Division; Colonic Neoplasms; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; G2 Phase; HT29 Cells; Humans; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2003 |
Resveratrol-induced modification of polyamine metabolism is accompanied by induction of c-Fos.
Topics: Acetyltransferases; Adenocarcinoma; Adenosylmethionine Decarboxylase; Anticarcinogenic Agents; Base Sequence; Caco-2 Cells; Catechin; Colonic Neoplasms; DNA Primers; Gene Expression Regulation; Humans; Ornithine Decarboxylase; Polyamines; Proto-Oncogene Proteins c-fos; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes | 2003 |
Synthesis and evaluation of cytotoxicity of stilbene analogues.
Topics: Antineoplastic Agents; Colonic Neoplasms; Drug Screening Assays, Antitumor; Humans; In Vitro Techniques; Lung Neoplasms; Phytoalexins; Plant Extracts; Resveratrol; Sesquiterpenes; Stilbenes; Structure-Activity Relationship; Terpenes; Tumor Cells, Cultured | 2003 |
Antitumor effect of resveratrol oligomers against human cancer cell lines and the molecular mechanism of apoptosis induced by vaticanol C.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspases; Cell Division; Colonic Neoplasms; Enzyme Activation; Humans; Membrane Potentials; Mitochondria; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2003 |
Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells.
Topics: Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Caspases; Cell Line, Tumor; Colonic Neoplasms; Cytochromes c; Enzyme Activation; Enzyme Inhibitors; Fas Ligand Protein; fas Receptor; Flow Cytometry; Genes, Dominant; Genetic Vectors; Humans; Immunoblotting; Ligands; Lipid Metabolism; Membrane Glycoproteins; Membrane Microdomains; Microscopy, Fluorescence; Mitochondria; Precipitin Tests; Protein Conformation; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Signal Transduction; Stilbenes; Time Factors; Transfection | 2003 |
Resveratrol analog (Z)-3,5,4'-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Binding Sites; Caco-2 Cells; Cell Cycle; Cell Division; Colchicine; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Gout Suppressants; Humans; Microtubules; Mitosis; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Polyamines; Polymers; Resveratrol; Stilbenes; Tubulin; Tubulin Modulators; Vinblastine | 2003 |
Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Carcinoma; Caspases; Cell Line, Tumor; Colonic Neoplasms; fas Receptor; Flow Cytometry; Humans; Ligands; Lipid Metabolism; Lipids; Membrane Glycoproteins; Membrane Microdomains; Mitochondria; Nystatin; Proto-Oncogene Proteins c-bcl-2; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Resveratrol; Signal Transduction; Stilbenes; Time Factors; TNF-Related Apoptosis-Inducing Ligand; Transfection; Tumor Necrosis Factor-alpha | 2004 |
Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells.
Topics: Adenoma; Animals; Antineoplastic Agents, Phytogenic; Chemoprevention; Colonic Neoplasms; Cyclooxygenase 2; Diet; Dinoprostone; Female; Genes, APC; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Prostaglandin-Endoperoxide Synthases; Resveratrol; Ribonucleotide Reductases; Stilbenes; Tissue Distribution | 2005 |
Effect of resveratrol on angiogenesis and platelet/fibrin-accelerated tumor growth in the chick chorioallantoic membrane model.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Line; Chick Embryo; Chorioallantoic Membrane; Colonic Neoplasms; Endothelium, Vascular; Fibroblast Growth Factor 2; Fibrosarcoma; Flavonoids; Humans; Neovascularization, Pathologic; Platelet Aggregation Inhibitors; Resveratrol; Stilbenes; Tumor Suppressor Protein p53 | 2005 |
Chemopreventive effect of trans-resveratrol--a phytoalexin against colonic aberrant crypt foci and cell proliferation in 1,2-dimethylhydrazine induced colon carcinogenesis.
Topics: 1,2-Dimethylhydrazine; Animals; Anticarcinogenic Agents; Antigens, Nuclear; Carcinogens; Cell Proliferation; Colon; Colonic Neoplasms; Enzyme Inhibitors; Intestinal Mucosa; Male; Nuclear Proteins; Phytoalexins; Plant Extracts; Rats; Rats, Wistar; Resveratrol; Sesquiterpenes; Stilbenes; Terpenes; Thiobarbituric Acid Reactive Substances | 2006 |
Functional proteomics of resveratrol-induced colon cancer cell apoptosis: caspase-6-mediated cleavage of lamin A is a major signaling loop.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Caspase 6; Caspases; Cell Line, Tumor; Colonic Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Lamin Type A; Proteomics; Resveratrol; Signal Transduction; Stilbenes; Transgenes; Tumor Suppressor Protein p53 | 2006 |
Caspase-2 triggers Bax-Bak-dependent and -independent cell death in colon cancer cells treated with resveratrol.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Inducing Factor; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; BH3 Interacting Domain Death Agonist Protein; Caspase 2; Caspase 3; Caspase 8; Caspase 9; Caspases; Colonic Neoplasms; Cytochromes c; Cytosol; Endodeoxyribonucleases; Fibroblasts; Green Fluorescent Proteins; HCT116 Cells; Humans; Mice; Mitochondria; Poly(ADP-ribose) Polymerases; Protein Conformation; Resveratrol; Stilbenes | 2006 |
Peroxisome proliferator-activated receptor gamma as a molecular target of resveratrol-induced modulation of polyamine metabolism.
Topics: Acetyltransferases; Antineoplastic Agents, Phytogenic; Biogenic Polyamines; Caco-2 Cells; Cell Growth Processes; Colonic Neoplasms; Enzyme Activation; HCT116 Cells; Humans; Imidazoles; p38 Mitogen-Activated Protein Kinases; PPAR gamma; Pyridines; Resveratrol; Stilbenes; Transcription, Genetic; Transfection | 2006 |
Dietary supplementation of resveratrol suppresses colonic tumour incidence in 1,2-dimethylhydrazine-treated rats by modulating biotransforming enzymes and aberrant crypt foci development.
Topics: 1,2-Dimethylhydrazine; Animals; Antineoplastic Agents, Phytogenic; Bacteria; Carcinogens; Colon; Colonic Neoplasms; Dietary Supplements; Disease Models, Animal; Feces; Glycoside Hydrolases; Intestinal Mucosa; Male; Nitroreductases; Polysaccharide-Lyases; Precancerous Conditions; Rats; Rats, Wistar; Resveratrol; Stilbenes; Sulfatases | 2006 |
Effect of resveratrol on proliferation and telomerase activity of human colon cancer cells in vitro.
Topics: Angiogenesis Inhibitors; Anticarcinogenic Agents; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; DNA-Binding Proteins; Humans; Resveratrol; Stilbenes; Telomerase | 2006 |
Anti-mitotic properties of resveratrol analog (Z)-3,5,4'-trimethoxystilbene.
Topics: Antineoplastic Agents, Phytogenic; Caco-2 Cells; Cell Cycle; Cell Proliferation; Colonic Neoplasms; Dose-Response Relationship, Drug; Electrophoresis, Agar Gel; Flow Cytometry; Humans; Mitosis; Resveratrol; Stereoisomerism; Stilbenes; Tubulin; Tubulin Modulators | 2006 |
Elevated gadd153/chop expression during resveratrol-induced apoptosis in human colon cancer cells.
Topics: Apoptosis; Colonic Neoplasms; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; MAP Kinase Signaling System; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Stilbenes; Transcription Factor CHOP; Transcription, Genetic | 2007 |
Transgenic alfalfa that accumulates piceid (trans-resveratrol-3-O-beta-D-glucopyranoside) requires the presence of beta-glucosidase to inhibit the formation of aberrant crypt foci in the colon of CF-1 mice.
Topics: Acyltransferases; Animals; beta-Glucosidase; Colonic Neoplasms; Disease Models, Animal; Female; Glucosides; Humans; Medicago sativa; Mice; Mice, Inbred Strains; Plants, Genetically Modified; Precancerous Conditions; Random Allocation; Resveratrol; Stilbenes | 2007 |
Resveratrol induces pro-apoptotic endoplasmic reticulum stress in human colon cancer cells.
Topics: Anticarcinogenic Agents; Apoptosis; Blotting, Western; Caspases; Colonic Neoplasms; DNA-Binding Proteins; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Eukaryotic Initiation Factor-2; Flow Cytometry; Heat-Shock Proteins; HT29 Cells; Humans; Molecular Chaperones; Nuclear Proteins; Phosphorylation; Regulatory Factor X Transcription Factors; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Transcription Factor CHOP; Transcription Factors; X-Box Binding Protein 1 | 2007 |
Inhibitory effects of trans-resveratrol analogs molecules on the proliferation and the cell cycle progression of human colon tumoral cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Membrane Permeability; Colonic Neoplasms; DNA Replication; DNA, Neoplasm; Flow Cytometry; Humans; Resveratrol; Stilbenes; Structure-Activity Relationship; Xenobiotics | 2008 |
Resveratrol displays converse dose-related effects on 5-fluorouracil-evoked colon cancer cell apoptosis: the roles of caspase-6 and p53.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 6; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Activation; Fluorouracil; HCT116 Cells; Humans; Inhibitory Concentration 50; Resveratrol; Stilbenes; Tumor Suppressor Protein p53 | 2008 |
Low concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: implications for colon cancer prevention.
Topics: Anticarcinogenic Agents; Cell Cycle; Cell Division; Cell Line; Cell Line, Tumor; Cell Size; Colon; Colonic Neoplasms; Humans; Intestinal Mucosa; Resveratrol; Stilbenes; Wnt Proteins | 2008 |
Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Caco-2 Cells; Cell Cycle; Cell Division; Colonic Neoplasms; Drug Screening Assays, Antitumor; Humans; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Polyamines; Resveratrol; Rosales; Stilbenes; Wine | 2000 |
p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents.
Topics: Adenocarcinoma; Alleles; Amino Acid Chloromethyl Ketones; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Benzothiazoles; Butyrates; Cisplatin; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cysteine Proteinase Inhibitors; Demecolcine; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fluorouracil; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Intracellular Membranes; Membrane Potentials; Mitochondria; Neoplasm Proteins; Recombination, Genetic; Resveratrol; Stilbenes; Thiazoles; Toluene; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2001 |
Do wine polyphenols modulate p53 gene expression in human cancer cell lines?
Topics: Antioxidants; Breast Neoplasms; Caffeic Acids; Catechin; Colonic Neoplasms; Flavonoids; Fluoroimmunoassay; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Models, Structural; Phenols; Polymers; Quercetin; Resveratrol; Stilbenes; Time Factors; Tumor Cells, Cultured; Wine | 2001 |
Resveratrol induces colon tumor cell apoptosis independently of p53 and precede by epithelial differentiation, mitochondrial proliferation and membrane potential collapse.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Differentiation; Cell Division; Colonic Neoplasms; Epithelial Cells; Humans; Membrane Potentials; Mitochondria; Resveratrol; Stilbenes; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2001 |
Vaticanol C, a novel resveratrol tetramer, inhibits cell growth through induction of apoptosis in colon cancer cell lines.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Colonic Neoplasms; DNA, Neoplasm; Humans; Molecular Weight; Plant Epidermis; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2002 |
Resveratrol enhances the differentiation induced by butyrate in caco-2 colon cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Butyrates; Caco-2 Cells; Cell Differentiation; Colonic Neoplasms; Drug Synergism; Humans; Resveratrol; Stilbenes | 2002 |